ADAPTIVE BIOTECHNOLOGIES CORPORATION - COMMON STOC

Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

03 июн 2021 07:30:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Conferences

20 май 2021 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Reports First Quarter 2021 Financial Results

05 май 2021 16:05:01 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference

27 апр 2021 16:05:01 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021

12 апр 2021 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen

17 мар 2021 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection

05 мар 2021 18:44:52 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Present at the Cowen 41st Annual Healthcare Conference

25 фев 2021 16:05:01 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2020 Financial Results

24 фев 2021 16:05:01 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio

23 фев 2021 09:15:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection

23 фев 2021 07:30:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

02 фев 2021 16:05:00 Источник Nasdaq GlobeNewswire

Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics

11 янв 2021 16:01:00 Источник Nasdaq GlobeNewswire